Buch, Englisch, Band 88, 242 Seiten, Paperback, Format (B × H): 155 mm x 235 mm, Gewicht: 400 g
Proceedings of the Symposium on New Drugs and Devices October 15¿16, 1987, Philadelphia, Pennsylvania
Buch, Englisch, Band 88, 242 Seiten, Paperback, Format (B × H): 155 mm x 235 mm, Gewicht: 400 g
Reihe: Developments in Cardiovascular Medicine
ISBN: 978-1-4612-8980-7
Verlag: Springer US
Zielgruppe
Research
Autoren/Hrsg.
Weitere Infos & Material
I Epidemiology, Pathophysiology, Classification.- 1. Epidemiology and prevalence of silent myocardial ischemia, and prognosis in asymptomatic patients.- 2. Pathophysiology of ischemia: Why are some episodes silent?.- 3. Myocardial ischemia as a useful functional indicator of risk in patients with coronary artery disease.- 4. The diagnostic and prognostic value of exercise ECG and radionuclide markers of ischemia in asymptomatic and symptomatic populations.- 5. An integrated clinical classification for ischemic heart disease: A combined assessment of severity of coronary disease, left ventricular function and myocardial ischemia.- Panel Discussion.- II Detection and Prognosis.- 6. Methods to detect ischemia using ambulatory (Holter) electrocardiography.- 7. The prognostic significance of silent myocardial ischemia during exercise testing.- 8. The role of radionuclide techniques in the evaluation of patients with silent myocardial ischemia.- Panel Discussion.- 9. Longitudinal (natural history) studies of silent myocardial ischemia.- 10. Silent myocardial ischemia and sudden cardiac death.- Panel Discussion.- IV Therapy and FDA Claims.- 11. Antianginal drug therapy for silent myocardial ischemia: Adrenergic blockers and calcium entry blockers.- 12. Therapy for silent ischemia: Nitrates.- 13. What are the FDA requirements to obtain a claim for the indication of silent ischemia?.- Panel Discussion.- V Combination Drug Therapy—FDA Issues.- 14. Combination drug therapy: What studies are required to obtain approval?.- Participant List.